Skip to main content
Explore URMC

Multiple Cancers: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Research Question:
Will matching certain drugs or drug combinations in adults whose tumors have specific gene abnormalities; effectively treat their cancer, regardless of their cancer type?

Basic Study Information

If you decide to participate in this study, your tumor cells will be tested to find out if they have a gene change or mutation targeted by one or more of the drugs used in this study. If you have a gene change or mutation that matches a substudy, you will be asked if you want to participate in a specific substudy.

Location: Cancer Center
Study Web URL:
Study Reference #: CMLT17117

Lead Researcher (Principal Investigator)

Lead Researcher: Marcus Noel

Study Contact Information

Study Coordinator: Laura Mitchell
Phone: (585) 275-7763

Additional Study Details

Return to Search